Primary Ovarian Carcinomas Display Multiple Methylator Phenotypes Involving Known Tumor Suppressor Genes
- 1 March 2001
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (3) , 1121-1127
- https://doi.org/10.1016/s0002-9440(10)64059-x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- CpG Islands in vertebrate genomesPublished by Elsevier ,2004
- p16/MTS1 inactivation in ovarian carcinomas: High frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumorsInternational Journal of Cancer, 1998
- Methylation of the BRCA1 gene in sporadic breast cancer.1997
- COBRA: a sensitive and quantitative DNA methylation assayNucleic Acids Research, 1997
- Rare mutations and no hypermethylation at theCDKN2A locus in epithelial ovarian tumoursInternational Journal of Cancer, 1997
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- The relationship of DNA methylation to cancer.1996
- Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.1995
- Hypermethylation at a chromosome 17 ?Hot spot? is a common event in ovarian cancer*1Human Pathology, 1995
- Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.1991